Axovant Gene Therapies to Host Virtual Parkinson’s Disease R&D Day on October 30, 2020

NEXT STORY
Global Home Healthcare Market (2020 to 2025) – Untapped Developing Regions Presents Opportunities
PREV STORY
MediciNova, in Collaboration with the University of Sydney and the Australasian Gastro-Intestinal Trials Group, Announces Plans for a Multi-center, Phase 2b Study to Evaluate MN-166 (ibudilast) in Chemotherapy-Induced Peripheral Neuropathy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Agios Announces Initiation of Global Phase 3 Trial (ACTIVATE) of AG-348 in Adults with Pyruvate Kinase Deficiency Who Are Not Regularly Transfused

- Broad Late-stage Development Plan in Place with Two Pivotal Trials and Patient Registry ...

author_avatar
NASDAQ Market News

Roche reports solid results in 2020

author_avatar
NASDAQ Market News

Progenics to Mail Letter to Shareholders

author_avatar
NASDAQ Market News